Description:

Registration required.

This webinar is part of the IPHAM Seminar Series, a weekly public health webinar series hosted by the Institute for Public Health and Medicine (IPHAM) at Northwestern University.

Guest:
Anand Srivastava, MD, MPH
Assistant Professor of Medicine
Center for Translational Metabolism and Health
Institute for Public Health and Medicine
Division of Nephrology and Hypertension
Northwestern University Feinberg School of Medicine

Anand Srivastava, MD, MPH is an Assistant Professor of Medicine in the Division of Nephrology and Hypertension and a core member of the Center for Translational Metabolism and Health within the Institute for Public Health and Medicine at Northwestern University Feinberg School of Medicine. He received his medical degree from Saint Louis University and completed his internal medicine residency at UT Southwestern Medical Center. He went on to complete his nephrology fellowship at the Joint Brigham & Women’s and Massachusetts General Hospital program. He subsequently completed a postdoctoral fellowship in clinical research at Harvard Medical School during which time he obtained a Master’s in Public Health from the Harvard T.H. Chan School of Public Health. Dr. Srivastava’s research focus is in patient-oriented research focused on the discovery and validation of novel non-invasive blood, urine, and imaging biomarkers that will identify high-risk patients with kidney diseases to optimize the conduct of clinical trials and serve as tools for drug development. He currently serves as the site principal investigator for STOP-COVID, a multicenter cohort study of over 5000 patients admitted to intensive care units across the United States to assess risk factors associated with adverse clinical outcomes in critically ill patients with COVID-19.

For more public health news, events, and announcements, visit the IPHAM website: https://feinberg.northwestern.edu/ipham